BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $882 | -27.6% | 22,507 | -29.8% | 0.01% | -36.4% |
| Q3 2023 | $1,219 | -31.4% | 32,041 | -17.2% | 0.02% | -29.0% |
| Q2 2023 | $1,776 | -33.8% | 38,680 | -40.9% | 0.03% | -40.4% |
| Q1 2023 | $2,681 | -82.9% | 65,424 | -78.6% | 0.05% | -83.5% |
| Q4 2022 | $15,649 | -99.9% | 305,104 | -45.3% | 0.32% | -51.5% |
| Q3 2022 | $30,236,000 | -21.2% | 558,267 | -6.2% | 0.65% | -16.5% |
| Q2 2022 | $38,386,000 | -18.4% | 594,936 | -1.5% | 0.78% | -5.4% |
| Q1 2022 | $47,014,000 | -9.7% | 604,156 | -0.1% | 0.82% | -6.9% |
| Q4 2021 | $52,082,000 | +7.5% | 604,803 | +0.4% | 0.88% | -4.4% |
| Q3 2021 | $48,446,000 | -0.9% | 602,336 | -0.8% | 0.92% | -1.0% |
| Q2 2021 | $48,893,000 | -3.7% | 607,363 | +0.9% | 0.93% | -8.7% |
| Q1 2021 | $50,785,000 | +5.5% | 602,151 | +0.4% | 1.02% | -0.5% |
| Q4 2020 | $48,142,000 | +4.5% | 599,980 | +4.7% | 1.03% | -5.0% |
| Q3 2020 | $46,082,000 | -2.7% | 573,019 | +4.2% | 1.08% | -12.6% |
| Q2 2020 | $47,342,000 | +5.5% | 549,852 | -0.6% | 1.24% | -9.6% |
| Q1 2020 | $44,893,000 | -8.6% | 552,936 | -1.6% | 1.37% | +6.0% |
| Q3 2019 | $49,136,000 | +9.4% | 561,743 | +2.4% | 1.29% | -23.0% |
| Q2 2019 | $44,913,000 | +0.9% | 548,392 | +0.1% | 1.68% | -1.8% |
| Q1 2019 | $44,530,000 | +23.5% | 547,660 | -0.0% | 1.71% | +11.0% |
| Q4 2018 | $36,056,000 | -13.6% | 547,792 | +1.1% | 1.54% | -1.9% |
| Q3 2018 | $41,752,000 | +4.0% | 541,598 | -0.4% | 1.57% | -4.0% |
| Q2 2018 | $40,145,000 | +12.4% | 543,673 | -1.0% | 1.63% | +10.7% |
| Q1 2018 | $35,717,000 | -0.6% | 549,147 | -1.2% | 1.48% | +3.1% |
| Q4 2017 | $35,915,000 | +0.2% | 555,623 | -2.7% | 1.43% | -4.7% |
| Q3 2017 | $35,829,000 | +3.5% | 570,979 | -0.1% | 1.50% | -3.6% |
| Q2 2017 | $34,616,000 | +15.7% | 571,789 | -0.8% | 1.56% | +14.5% |
| Q1 2017 | $29,906,000 | +14.8% | 576,674 | -1.8% | 1.36% | +10.7% |
| Q4 2016 | $26,048,000 | -6.7% | 587,459 | +0.2% | 1.23% | -8.8% |
| Q3 2016 | $27,920,000 | +4.2% | 586,552 | -1.0% | 1.35% | +1.9% |
| Q2 2016 | $26,784,000 | +5.9% | 592,301 | -3.8% | 1.32% | +4.2% |
| Q1 2016 | $25,296,000 | +7.4% | 615,771 | -0.3% | 1.27% | +4.4% |
| Q4 2015 | $23,555,000 | +16.0% | 617,431 | -0.2% | 1.22% | +9.1% |
| Q3 2015 | $20,314,000 | -52.6% | 618,390 | +0.8% | 1.11% | -48.2% |
| Q2 2015 | $42,895,000 | +3.5% | 613,403 | +1.3% | 2.15% | +4.4% |
| Q1 2015 | $41,460,000 | +1.4% | 605,260 | +8.5% | 2.06% | +4.4% |
| Q4 2014 | $40,893,000 | +5.6% | 557,961 | +3.4% | 1.97% | +5.3% |
| Q3 2014 | $38,739,000 | -0.1% | 539,768 | +0.6% | 1.87% | +0.3% |
| Q2 2014 | $38,778,000 | -1.7% | 536,346 | +0.1% | 1.87% | -4.8% |
| Q1 2014 | $39,429,000 | +7.5% | 535,863 | +1.6% | 1.96% | +7.0% |
| Q4 2013 | $36,672,000 | +7.0% | 527,277 | +1.1% | 1.83% | -1.3% |
| Q3 2013 | $34,270,000 | -6.2% | 521,689 | -1.1% | 1.86% | -7.7% |
| Q2 2013 | $36,536,000 | – | 527,450 | – | 2.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |